Lon T. Spada;Sougato Boral;Xialing Guo;Jane Guo Shiah;Thomas C. Malone;Jeffrey L. Edelman;Gerald W. DeVries;Julie A. Wurster;Patrick Hughes
发明人:
Lon T. Spada,Jane Guo Shiah,Patrick Hughes,Thomas C. Malone,Gerald W. DeVries,Jeffrey L. Edelman,Julie A. Wurster,Xialing Guo,Sougato Boral
申请号：
US12380493
公开号：
US20120238558A9
申请日:
2009.02.26
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention relates to drug delivery systems comprising ocular implant, which include organic molecules, capable of modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation, in combination with a polymer, which polymer serves to control, modify, modulate and/or slow the release of the therapeutic component into the environment of the eye in which said composite is placed.
